SHORT-TERM OUTCOMES IN PATIENTS WITH SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH EITHER TOCILIZUMAB OR ANAKINRA IN A REAL-WORLD SETTING IN THE UNITED KINGDOM

被引：0
|
作者：
Kearsley-Fleet, Lianne [1 ]
De Cock, Diederik [1 ]
Baildam, Eileen [2 ]
Beresford, Michael W. [3 ]
Foster, Helen E. [4 ,5 ]
Southwood, Taunton R. [6 ,7 ]
Thomson, Wendy [8 ,9 ]
Hyrich, Kimme L. [1 ,8 ]
机构：
[1] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Ctr Epidemiol, Manchester, Lancs, England
[2] Univ Liverpool, Alder Hey Childrens NHS Fdn Trust, Dept Paediat Rheumatol, Clin Acad, Liverpool, Merseyside, England
[3] Univ Liverpool, Alder Hey Childrens NHS Fdn Trust, Inst Translat Med Child Health, Liverpool, Merseyside, England
[4] Newcastle Univ, Newcastle, NSW, Australia
[5] Great North Childrens Hosp, Inst Cellular Med & Paediat Rheumatol, Newcastle, NSW, Australia
[6] Univ Birmingham, Inst Child Hlth, Birmingham, W Midlands, England
[7] Birmingham Childrens Hosp, Birmingham, W Midlands, England
[8] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Natl Inst Hlth Res Manchester Musculoskeletal Bio, Manchester, Lancs, England
[9] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Ctr Genet & Genom, Manchester, Lancs, England
来源：
RHEUMATOLOGY | 2017年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
07
引用
收藏
页数：2
相关论文
共 50 条
  • [41] SUCCESSFUL TREATMENT WITH TOCILIZUMAB EVERY 4 WEEKS DISTINGUISHES LOW DISEASE ACTIVITY GROUP AND POSSIBILITY TO ACHIEVE DRUG-FREE REMISSION IN PATIENTS WITH SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS
    Kostik, M. M.
    Dubko, M. F.
    Masalova, V. V.
    Snegireva, L. S.
    Kornishina, T. L.
    Likhacheva, T. S.
    Chikova, I. A.
    Isupova, E. A.
    Kuchinskaya, E. M.
    Glebova, N. I.
    Buchinskaya, N. V.
    Gaidar, E. V.
    Kalashnikova, O. V.
    Chasnyk, V. G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 586 - 586
  • [42] Reasons for Initiating Canakinumab among Patients with Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease in the U.S. Real-World Settings
    Peter Hur
    Esther Yi
    Raluca Ionescu-Ittu
    Ameur M. Manceur
    Kathleen G. Lomax
    Jordan Cammarota
    Jipan Xie
    Raju Gautam
    Priscila Nakasato
    Navneet Sanghera
    Nina Kim
    Alexei A. Grom
    [J]. Rheumatology and Therapy, 2022, 9 : 265 - 283
  • [43] DISABILITY AND HEALTH-RELATED QUALITY OF LIFE OUTCOMES IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH TOCILIZUMAB IN A PHASE 3 RANDOMIZED CONTROLLED TRIAL
    Ruperto, Nicolino
    Chen, Chen
    Martini, Alberto
    Espada, Graciela
    Joos, Rik
    Akikusa, Jonathan
    Chaitow, Jeffrey
    Gamir, Maria Luz Gamir
    Kimura, Yukiko
    Rietschel, Christoph
    Siri, Daniel
    Smolewska, Elzbieta
    Schmeling, Heinrike
    Brown, Diane
    De Benedetti, Fabrizio
    Lovell, Daniel J.
    Huang, Bin
    Brunner, Hermine
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 981 - 982
  • [44] Real-world outcomes in older adults treated with immunotherapy: A United Kingdom multicenter series of 2,049 patients.
    Olsson-Brown, Anna Claire
    Baxter, Mark
    Dobeson, Caroline
    Feeney, Laura
    Lee, Rebecca
    Maynard, Alec
    Mirza, Shagufta
    Parikh, Shefali
    Rodgers, Lisa Jane
    Salawu, Abdulazeez
    Shotton, Rohan
    Tinsley, Nadina
    Heseltine, Jonathan
    Cotton, Jenny
    Hughes, Daniel
    Zhao, Steven
    Parry, James
    Jones, Christopher
    Rowe, Michael
    Tivey, Ann
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [45] Real-world treatment patterns, adverse events and clinical outcomes in patients with chronic lymphocytic leukaemia treated with ibrutinib in the United Kingdom
    Xie, J.
    Yong, A. S. M.
    Waweru, C.
    Sorof, T. -A.
    Goyal, R. K.
    Davis, K. L.
    Hillmen, P.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 221 - 221
  • [46] Disability and Health-Related Quality of Life Outcomes in Patients with Systemic or Polyarticular Juvenile Idiopathic Arthritis Treated with Tocilizumab in Randomized Controlled Phase 3 Trials
    Brunner, Hermine
    Chen, Chen
    Martini, Alberto
    Espada, Graciela
    Joos, Rik
    Akikusa, Jonathan
    Chaitow, Jeffrey
    Garnir, Maria Luz Garnir
    Kimura, Yukiki
    Rietsche, Christoph
    Siri, Daniel
    Smolewska, Elzbieta
    Schmeling, Heinrike
    Brown, Diane
    De Benedetti, Fabrizio
    Lovell, Daniel J.
    Huang, Bin
    Ruperto, Nicolino
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [47] LONG TERM SAFETY FOR TOCILIZUMAB IN REAL-WORLD SETTING; 3 YEAR FOLLOW-UP POSTMARKETING SURVEILLANCE OF 5573 PATIENTS WITH RHEUMATOID ARTHRITIS IN JAPAN
    Yamamoto, K.
    Goto, H.
    Hirao, K.
    Nakajima, A.
    Origasa, H.
    Nakasone, A.
    Takagi, N.
    Totsuka, K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 725 - 726
  • [48] Real-world short-term outcomes and treatment regimen comparisons in patients with metastatic renal cell carcinoma treated with first-line immune combinations
    Masato Kikuta
    Sei Naito
    Takahiro Osawa
    Kazuyuki Numakura
    Takafumi Narisawa
    Yuki Takai
    Mayu Yagi
    Yuya Sekine
    Ojiro Tokairin
    Nobuo Shinohara
    Tomonori Habuchi
    Norihiko Tsuchiya
    [J]. BMC Cancer, 25 (1)
  • [49] Analysis of perioperative clinical features and complications after orthopaedic surgery in rheumatoid arthritis patients treated with tocilizumab in a real-world setting: results from the multicentre TOcilizumab in Perioperative Period (TOPP) study
    Momohara, Shigeki
    Hashimoto, Jun
    Tsuboi, Hideki
    Miyahara, Hisaaki
    Nakagawa, Natsuko
    Kaneko, Atsushi
    Kondo, Naoki
    Matsuno, Hiroaki
    Wada, Takahiko
    Nonaka, Tohgo
    Kanbe, Katsuaki
    Takagi, Haruki
    Murasawa, Akira
    Matsubara, Tsukasa
    Suguro, Toru
    [J]. MODERN RHEUMATOLOGY, 2013, 23 (03) : 440 - 449
  • [50] Association between Body Mass Index and Short-Term Clinical Outcomes in Critically Ill Patients with Sepsis: A Real-World Study
    Lin, Shan
    Ge, Shanhui
    He, Wanmei
    Zeng, Mian
    [J]. BIOMED RESEARCH INTERNATIONAL, 2020, 2020
12345